Herjan Coelingh Bennink
Gründer bei Pantarhei Bioscience BV
Profil
Herjan Coelingh Bennink is the founder of Pantarhei Bioscience BV (founded in 2000) and Pantarhei Oncology BV (founded in 2014), where he holds the titles of President & Director and Chairman-Supervisory Board, respectively.
He is currently the Chairman of Oxytone Bioscience BV.
Dr. Bennink's former positions include President & Chief Executive Officer at Delphi Bioscience BV, Non-Executive Director at Mithra Pharmaceuticals SA, and Executive Vice President at Organon BioSciences NV.
He also served as a Professor at Université Libre de Bruxelles from 1997 to 2005.
Dr. Bennink received his doctorate degrees from Erasmus University Rotterdam in 1969 and the University of Utrecht in 1980.
Aktive Positionen von Herjan Coelingh Bennink
Unternehmen | Position | Beginn |
---|---|---|
Pantarhei Bioscience BV
Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | Gründer | 28.12.2000 |
Pantarhei Oncology BV | Gründer | 01.01.2014 |
Oxytone Bioscience BV | Vorsitzender | - |
Ehemalige bekannte Positionen von Herjan Coelingh Bennink
Unternehmen | Position | Ende |
---|---|---|
Université Libre de Bruxelles | Corporate Officer/Principal | 01.01.2005 |
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | 01.01.2000 |
MITHRA PHARMACEUTICALS S.A. | Direktor/Vorstandsmitglied | - |
Delphi Bioscience BV
Delphi Bioscience BV Pharmaceuticals: MajorHealth Technology Delphi Bioscience BV develops health screening solutions for vaginal and cervical infections. It offers Delphi Screener, a self-sampling device which can be used by women or doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam. The company was founded in 2006 and is headquartered in Scherpenzeel, the Netherlands. | Vorstandsvorsitzender | - |
Ausbildung von Herjan Coelingh Bennink
Erasmus University Rotterdam | Doctorate Degree |
University of Utrecht | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MITHRA PHARMACEUTICALS S.A. | Health Technology |
Private Unternehmen | 5 |
---|---|
Delphi Bioscience BV
Delphi Bioscience BV Pharmaceuticals: MajorHealth Technology Delphi Bioscience BV develops health screening solutions for vaginal and cervical infections. It offers Delphi Screener, a self-sampling device which can be used by women or doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam. The company was founded in 2006 and is headquartered in Scherpenzeel, the Netherlands. | Health Technology |
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
Pantarhei Bioscience BV
Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | Health Technology |
Pantarhei Oncology BV | |
Oxytone Bioscience BV |